Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Recipharm to end operations in two facilities in Sweden

November 9, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Recipharm

Recipharm today announces that it will initiate a process with the intention of discontinuing manufacturing operations at its facilities in …
News
Press release
skin-222664_960_720

Gene therapy helps child regrow 80% of skin

November 9, 2017 Medical Communications, Research and Development biotech, drugs, gene therapy, pharma, pharmaceutical, stem cell

A young child has been brought back from the verge of death after an experimental combination of stem cell and …
News
shutterstock_206748499

17,000 English patients are surviving Stage 4 cancer for two years or more, new data shows

November 8, 2017 Research and Development Cancer, bladder cancer, breast cancer, colon cancer, lung cancer, pharma, prostate cancer

At least 17,000 people in the UK are living with Stage 4 cancer and have survived for two years or …
News
promotional_banner

The End Game: Payer Engagement Webinar

November 8, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Webinar, biotech, drugs, pharma, pharmaceutical

In our latest free to attend webinar, we have joined up with NDA to bring you the latest market access …
News
cellectis

Cellectis given another shot at off-the-shelf CAR-T

November 8, 2017 Medical Communications, Research and Development CAR-T, biotech, cellectis, drugs, pharma, pharmaceutical

It is easy to forget the very real dangers that CAR-T treatment present to patients after Novartis and Gilead both …
News
doctor_notes

Clinical trials still have a problem with ethnic minorities

November 8, 2017 Medical Communications, Research and Development biotech, clinical trials, drugs, ethnic minorities, pharma, pharmaceutical

Research, published in the Journal of Women’s Health, that aimed to determine the effects of the FDA’s guidance on the …
News
novartis_outside_1

Novartis’ Kisqali smashes Phase 3 primary endpoint in breast cancer for second time

November 8, 2017 Research and Development Cancer, Kisqali, Novartis, breast cancer, pharma

Novartis has revealed that its immunotherapy drug Kisqali (ribociclib) met its primary endpoint of progression-free survival in its second Phase …
News
online_survey_icon_or_logo_v2

Collaboration in Biopharma

November 7, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical

Dear Colleague,
News
mosquito

Breathalyser for malaria shows promise in trials

November 7, 2017 Manufacturing and Production, Research and Development biotech, drugs, malaria, pharma, pharmaceutical

Access to sophisticated rapid blood tests for malaria has improved dramatically in recent years but there are still issues in …
News
window-2387518_960_720

Clinical trial transparency: Letting the light in

November 6, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, clinical trial transparency, clinical trials, drugs, pharma, pharmaceutical

Transparency is one of those words for which the exact meaning has become clouded by murkier connotations. The chances are …
Feature
merckkgaahq

Merck KGaA posts promising osteoarthritis data

November 6, 2017 Research and Development, Sales and Marketing Merck KGaA, biotech, drugs, pharma, pharmaceutical

Merck KGaA’s share price is 7% down over the course of the year – a year that, on the pharmaceutical …
News
bacteria-1959386_960_720

Gut bacteria may be key to efficacy of immunotherapies

November 6, 2017 Research and Development, Sales and Marketing biotech, drugs, immunotherapy, pharma, pharmaceutical

Why immunotherapies are successful in some individuals and not in others is a matter of huge importance to both patients …
News
4420456374_64a3d7e6aa

Top Ten most popular articles on Pharmafile.com this week

November 3, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing drug, pharma, pharmaceuticals, top ten

As we move into November, we bring you another run down of the top ten most popular articles on Pharmafile.com …
News
gsk_boronia_australia

GSK’s experimental multiple myeloma scores Breakthrough designation with FDA

November 3, 2017 Medical Communications, Research and Development, Sales and Marketing Cancer, FDA, GSK, GlaxoSmithKline, multiple myeloma, pharma

GlaxoSmithKline is celebrating the FDA’s decision to award its experimental therapy GSK2857916 with Breakthrough Therapy Designation as a monotherapy in …
News
online

Tissue Regenix promotes new CEO from within

November 2, 2017 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing biotech, drugs, pharma, pharmaceutical, tissue regenix

Just over two weeks ago, Tissue Regenix announced that its long-standing CEO, Antony Odell, would be leaving the company. It …
Appointment
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026